Ingunn M. Stromnes, Ph.D.
Affiliations: | 2007 | University of Washington, Seattle, Seattle, WA |
Area:
ImmunologyGoogle:
"Ingunn Stromnes"Mean distance: 26716.5
Parents
Sign in to add mentor| Joan M. Goverman | grad student | 2007 | University of Washington | |
| (T cell determinants of central nervous system autoimmune disease.) | ||||
| Philip D Greenberg | post-doc | University of Washington (Microtree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tsai AK, Stromnes IM. (2023) CD39 deletion in TCR-engineered T cells enhances antitumour immunity. Gut |
| Patterson MT, Burrack AL, Xu Y, et al. (2023) Tumor-specific CD4 T cells instruct monocyte fate in pancreatic ductal adenocarcinoma. Cell Reports. 42: 112732 |
| Stromnes IM. (2023) IL18 at the Crossroads between Chronic Inflammation and T-cell Exhaustion in Pancreatic Cancer. Cancer Immunology Research. OF1 |
| Rollins MR, Raynor JF, Miller EA, et al. (2023) Germline T cell receptor exchange results in physiological T cell development and function. Nature Communications. 14: 528 |
| Burrack AL, Spartz EJ, Rollins MR, et al. (2022) Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate. Cancer Immunology, Immunotherapy : Cii |
| Burrack AL, Schmiechen ZC, Patterson MT, et al. (2022) Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer. Jci Insight. 7 |
| Stromnes IM, Hulbert A, Rollins MR, et al. (2022) Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer. Journal For Immunotherapy of Cancer. 10 |
| Burrack AL, Rollins MR, Spartz EJ, et al. (2021) CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model. Journal of Immunology (Baltimore, Md. : 1950) |
| Schmiechen ZC, Stromnes IM. (2020) Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma. Frontiers in Immunology. 11: 613815 |
| Schmiechen ZC, Burrack AL, Stromnes IM. (2020) Chemotherapy brings virtual memory T cells into reality for cancer therapy. Cellular & Molecular Immunology |